If you've been near peptide content this year, you've seen the headlines: "Peptides are legal again." "RFK Jr. just unbanned BPC-157."
This is exactly the kind of thing this newsletter exists to cut through — because what actually happened is narrower, and more interesting, than the headline.
The short version:
What happened in 2023 The FDA moved 19 widely-discussed peptides onto its Category 2 list — a "significant safety risk" designation that stopped licensed compounding pharmacies from preparing them. BPC-157, TB-500, CJC-1295, Ipamorelin, and Thymosin Alpha-1 were among them. The stated reasons: questions around immune response, manufacturing impurities, and limited large-scale human trial data.
What happened in 2026 In February, HHS Secretary Robert F. Kennedy Jr. announced that around 14 of those 19 would move back off the restricted list. The substances came off Category 2 in late April, and the FDA's Pharmacy Compounding Advisory Committee is scheduled to review them formally on July 23–24.
Here's the part the headlines skip Moving from Category 2 toward Category 1 governs exactly one thing: whether a compounding pharmacy can legally prepare a substance for a patient who has a prescription.
That's it.
It does not mean these peptides are now FDA-approved drugs. It does not mean they're available over the counter. And it's a separate world from the "research use only" market entirely.
Why this matters for you "Legal to compound" and "FDA-approved" are two very different statements. So are "a pharmacy can prepare this under prescription" and "this is safe to source anywhere." The reader who understands those distinctions makes very different decisions than the one reacting to a headline.
That's the whole point of research literacy — not memorizing which compound is trending, but understanding the framework underneath the noise, so the next viral headline doesn't make the decision for you.
To stay on top of the rapidly changing industry and network with researchers like you discussing all things biohacking and human optimization…
Stay curious, The Biohacker Network Team
PS: Both APR and Signa codes are still live, check the announcements channel in the discord for the full details